Smart MCs technology stands as a revolutionary step in oncological research and diagnostics, providing a microfluidic solution for the label-free separation of single CTCs and clusters. This device significantly enhances the workflow by offering a rapid and less invasive method to isolate CTCs, thereby preserving their biological integrity. Its gentle sorting mechanism minimizes shear force, ensuring the preservation of crucial cellular characteristics for subsequent analyses.
Employing Smart MCs technology, researchers and clinicians can achieve high sample purity with approximately a four-log depletion of white blood cells, which is critical for obtaining accurate diagnostic and research data. Furthermore, the technology maintains cell viability post-isolation, which is essential for downstream applications such as phenotypic and genotypic characterization. Designed for sterility and disposability, the device meets the rigorous standards of clinical use, making it a valuable tool for both clinical settings and research laboratories focusing on cancer progression and metastasis.
Your Application, Our Commitment: Tell us more about your application, and let us craft the perfect solution for you. Advancing your research and production is not just a goal—it’s a guarantee. Reach out today for a personalized quote and embark on a journey of discovery and innovation.
| Applications | Label-Free Sorting of Circulating Tumour Cells from Peripheral Blood Cells |
|---|---|
| Device Material | PDMS |
| Sterility | Upon Request: Autoclave & Gamma Irradiation |
| Cell Size Separation | ~15micron from ~10micron cells |
| Certicate of Analysis | Yes |
